Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial

This study aimed to evaluate the immunogenicity non-inferiority and safety of the quadrivalent inactivated split-virion influenza vaccine in participants ≥ 3 years old. A total of 3,328 participants were enrolled. Participants 3–8 years old were administered one or two doses of the investigational v...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianmin, Jiang, Feng, Zhao, Chenyan, Chai, Jing, Li, Lanshu, Guan, Qinghu, Li, Xiaoyu, Wang, Feiyu, Li, Ansheng, Gao, Hongxia, Wang, Minghui, Fu, Liandi, Nie, Fei, Ling, Weijun, Deng, Haobin, Zhou, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Influenza
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438852/
https://www.ncbi.nlm.nih.gov/pubmed/37587615
http://dx.doi.org/10.1080/21645515.2023.2245721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438852/
https://www.ncbi.nlm.nih.gov/pubmed/37587615
http://dx.doi.org/10.1080/21645515.2023.2245721

Ejemplares similares